InvestorWire NewsRoom


RYAH Group, Inc. (CSE: RYAH) Enters New Zealand Market
May 18, 2021

RYAH Group, Inc. (CSE: RYAH) Enters New Zealand Market

  • A partnership with Medical Kiwi LTD makes it possible for RYAH to enter the New Zealand Market
  • Medical Kiwi was the first South Island-based company to be granted a Medicinal Cannabis license from the Ministry of Health to cultivate
  • The potential market for medical cannabis in New Zealand is at NZ$1.5 billion

RYAH Group (CSE: RYAH), a health care analytics and technology company, has entered the New Zealand market through a definitive wholesale supply and distribution agreement with Medical Kiwi LTD ( This agreement enables RYAH’s suite of IoT devices and cloud-based data analytics to be used in pre-clinical and clinical trial settings and medical patient care alongside Medical Kiwi’s medical cannabis formulations. 

“Our new partnership with Medical Kiwi Ltd in New Zealand further expands our global clinical and distribution network for plant-based medicine and digital patient care,” said Gregory Wagner, CEO of RYAH Group Inc. and of RYAH Medtech, Inc.  

Medical Kiwi is a leader in research and development, manufacturing, cultivation and distribution of medical cannabis and medical devices in New Zealand. The Company has built a strong health-based, scientific and business savvy team. It offers assurance from seed to sale and has built a reputation on innovation, excellence, quality, transparency and service. It was the first South Island-based Company to be granted a Medicinal Cannabis license from the Ministry of Health to cultivate. 

It is difficult for importers of cannabis to enter the New Zealand market, and many who were once there are pulling out, unable to meet stiff new government standards ( Medical Kiwi’s medical cannabis formulations are cultivated, produced, and sold domestically. The analytics that RYAH’s IoT and cloud-based data analytics will help provide the necessary information the country desires in its journey to find safer, more effective medicinal products and better understand the medicinal effects. 

RYAH is not the cannabis supplier but instead creates partnerships that enable doctors and patients to personalize plant-based treatments to predict treatment outcomes better. The artificial intelligence platform aggregates and correlates HIPAA-compliant patient data throughout the patient session and formulation lifecycle. 

The Ministry of Health estimates that over 250,000 casual cannabis users use it for medicinal purposes, with a potential market estimated at NZ$1.5 billion ( 

“Our new relationship with Medical Kiwi presents an opportunity for both parties to drive innovation and to deliver cutting edge plant-based medical solutions in New Zealand,” stated Wagner.

In addition to the partnership, RYAH and Medical Kiwi are looking to explore the medical device registration of RYAH’s Smart-Inhaler, the first of its kind in New Zealand. 

For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Recent Articles

Release Categories

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).